{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:59:06Z","timestamp":1789556346979,"version":"build-2803163510"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T00:00:00Z","timestamp":1690675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AI159396"],"award-info":[{"award-number":["K23AI159396"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.1093\/cid\/ciad446","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T08:58:52Z","timestamp":1690534732000},"page":"1737-1738","source":"Crossref","is-referenced-by-count":4,"title":["Aminoglycoside Therapeutic Drug Monitoring: On Paper vs in Practice"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5071-9193","authenticated-orcid":false,"given":"Navaneeth","family":"Narayanan","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Administration & Center of Excellence in Pharmaceutical Translational Research and Education, Rutgers University Ernest Mario School of Pharmacy , Piscataway, New Jersey , USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School , New Brunswick, New Jersey , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"James S","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Oregon Health and Science University , Portland, Oregon , USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University , Portland, Oregon , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,30]]},"reference":[{"key":"2023121605160017000_ciad446-B1","article-title":"Infectious Diseases Society of America antimicrobial-resistant treatment guidance: gram-negative bacterial infections","author":"Tamma","year":"2023","journal-title":"Infect Dis Soc Am"},{"key":"2023121605160017000_ciad446-B2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/AAC.9.6.925","article-title":"Concentrations of gentamicin and amikacin in human kidneys","volume":"9","author":"Edwards","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"2023121605160017000_ciad446-B3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkm193","article-title":"Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Vidal","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2023121605160017000_ciad446-B4","author":"USCAST","year":"2019"},{"key":"2023121605160017000_ciad446-B5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMoa1801467","article-title":"Once-daily plazomicin for complicated urinary tract infections","volume":"380","author":"Wagenlehner","year":"2019","journal-title":"N Engl J Med"},{"key":"2023121605160017000_ciad446-B6","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/jac\/dkaa369","article-title":"Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis","volume":"75","author":"Elbaz","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2023121605160017000_ciad446-B7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/phar.2193","article-title":"Reappraisal of contemporary pharmacokinetic and pharmacodynamic principles for informing aminoglycoside dosing","volume":"38","author":"Bland","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2023121605160017000_ciad446-B8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coph.2017.09.009","article-title":"Use of Monte Carlo simulation and considerations for PK-PD targets to support antibacterial dose selection","volume":"36","author":"Trang","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"2023121605160017000_ciad446-B9","volume-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","author":"CLSI","year":"2023","edition":"33rd ed"},{"key":"2023121605160017000_ciad446-B10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/313692","article-title":"National survey of extended-interval aminoglycoside dosing","volume":"30","author":"Chuck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2023121605160017000_ciad446-B11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkx427","article-title":"MIC-based dose adjustment: facts and fables","volume":"73","author":"Mouton","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2023121605160017000_ciad446-B12","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2023121605160017000_ciad446-B13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2023121605160017000_ciad446-B14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health\u2014System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad446\/51122087\/ciad446.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/12\/1737\/54532135\/ciad446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/12\/1737\/54532135\/ciad446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:16:19Z","timestamp":1702685779000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/12\/1737\/7233761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,30]]},"references-count":14,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,7,30]]},"published-print":{"date-parts":[[2023,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad446","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,15]]},"published":{"date-parts":[[2023,7,30]]}}}